Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1998Movement Disorders

Ropinirole in the treatment of early Parkinson's disease: A 6‐month interim report of a 5‐year levodopa‐controlled study

View Full Paper
Ask AI
Bookmark
Share

Authors

OROlivier RascolUniversité Claude Bernard Lyon 1DBDavid J. BrooksBoston UniversityEBEhrout R. BruntUniversity of Groningen

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rascol et al. (1998) studied this question.

synapsesocial.com/papers/6a6e028ee5469ee92bdfe1dehttps://doi.org/10.1002/mds.870130111
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Levodopa‐induced dyskinesia1990 · 358 citations
  2. 2Intense oxidative DNA damage promoted by <scp>l</scp>‐DOPA and its metabolites implications for neurodegenerative disease1994 · 278 citations
  3. 3Accuracy of Clinical Diagnosis in Parkinsonism — A Prospective Study1991 · 597 citations
  4. 4Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6‐month interim report of a 3‐year study1998 · 130 citations
  5. 5Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease.1995 · 240 citations